Background
==========

*Candida glabrata*is a very rare cause of endophthalmitis following penetrating keratoplasty. We reviewed 12 reported cases of C*andida glabrata*endophthalmitis following penetrating keratoplasty with varying onset from 1978 to 2010, in which most of them had positive donor rim culture.

We report on a case of *Candida glabrata*endophthalmitis following an uneventful penetrating keratoplasty in an immunocompromised patient. Cultures of the donor rim and transport media did not grow any microorganism. The organism was successfully isolated from both, the aqueous and vitreous taps. A prompt recognition and appropriate management are essential in this condition.

Case presentation
=================

A 63-year-old gentleman with Fuch\'s endothelial dystrophy in both eyes underwent a penetrating keratoplasty in his right eye. He had multiple underlying medical problems, which included diabetes mellitus, hypertension, fatty liver secondary to hypertrigliseridemia and hypoadrenalism. He had been on oral dexamethasone 5 mg morning and 2.5 mg night dose since 3 years ago.

The donor cornea was harvested eleven hours postmortem from a 56-year-old gentleman who died from peritonitis secondary to perforated appendicitis, with underlying pulmonary hypertension, valvular heart disease and chronic obstructive pulmonary disease. Donor tissue was stored for nine days at 4°C in Optisol-GS culture solution.

The pre-op visual acuity was 6/60 with no improvement with pinhole in the right eye and hand movement with good projection of light in the left eye. There was evidence of bullous keratopathy and guttata at the endothelial layer of cornea in both eyes. The right eye was pseudophakic. There was a dense cataract in his left eye. The intraocular pressure was normal in both eyes. Pre-operative B-scan ultrasonography confirmed an intact retina with clear vitreous. Systemic evaluations included full blood picture and chest x-ray did not reveal foci of infection.

The penetrating keratoplasty was uneventful. On day one postoperatively, his visual acuity was counting fingers at 2 feet. There was a generalized epithelial defect over the whole corneal button. The epithelium healed completely after ten days.

At two weeks postoperative period, he complained of pain in the right eye and his visual acuity deteriorated to hand movement. The conjunctiva was congested and the corneal became hazy. There were multiple suture abscesses with retrocorneal plaques and a level of hypopyon (Figure [1](#F1){ref-type="fig"}). B-scan ultrasonography showed evidence of vitreous abscesses and a flat retina (Figure [2](#F2){ref-type="fig"}).

![**Anterior segment photograph showing multiple suture abscesses and retrocorneal white plaques at the donor host interface at 2 weeks postoperative period**.](1471-2415-10-18-1){#F1}

![B-scan ultrasonography showing evidence of vitreous abscess with an intact retina in his right eye](1471-2415-10-18-2){#F2}

There was no organism isolated from either the cultures of donor corneal rim or transport medium. However, both the aqueous and vitreous taps grew *Candida glabrata*. Conjunctiva swab from the fellow eye and blood culture were negative.

He was treated with a combination of treatment, which included topical Amphotericin B 0.15% hourly and 0.5 mg/kg/day of intravenous Amphotericin B daily for the duration of six weeks. An intravitreal injection of 5 μg Amphotericin B was given once while performing the aqueous and vitreous taps. 5 μg of Amphotericin B was injected intracamerally two weeks later. He was monitored closely for signs of Amphotericin B toxicity.

He did not develop any toxic effect or serious complication during the therapy except for a minimal elevation of liver enzymes. He showed an encouraging clinical improvement, though his final visual acuity remained poor due to the haziness of the corneal button.

Conclusions
===========

*Candida glabrata*endophthalmitis following penetrating keratoplasty is very rare but has devastating effects. It typically occurs within the first and second week post penetrating keratoplasty \[[@B1]-[@B4]\]. In contrast, there were cases occurred as early as 10 hours post transplantation or as late as 5 months post surgery \[[@B5]-[@B7]\]. Our patient developed features of endophthalmitis at two weeks post penetrating keratoplasty.

*Candida glabrata*, formerly known as *Torulopsis glabrata*is a non-dimorphic/haploid yeast that has recently emerged as an important nosocomial pathogen \[[@B8]\]. It can be found in normal healthy skin, respiratory, genitourinary and gastrointestinal systems. It is a highly opportunistic pathogen of the urogenital tract and the blood stream.

The prevalence is high in HIV positive patients and the elderly, other risk factors include prolonged hospitalization and prior antibiotic use \[[@B8]\]. Infection with *Candida glabrata*can be mucosal or systemic, and occurs more commonly in an immunocompromised or a debilitated host.

Table [1](#T1){ref-type="table"} summarizes 12 reported cases of *Candida glabrata*endophthalmitis in the literature from 1998-2010. All of the cases had either positive cultures of donor rim or transport medium \[[@B1]-[@B7],[@B9]-[@B12]\]. Both negative donor rim and transport medium cultures in postkeratoplasty endophthalmitis caused by *Candida glabrata*has never been reported previously. To the best of our knowledge, this is the first reported case of *Candida glabrata*postkeratoplasty endophthalmitis with negative donor rim and transport medium cultures.

###### 

Comparison between previously reported cases of *Candida glabrata*endophthalmitis following penetrating keratoplasty

  Author/Year                       Age/Gender      Indication for PK                             Onset of endophthalmitis   Culture                                                                                      Treatment                                                                                                                                              Side effects
  --------------------------------- --------------- --------------------------------------------- -------------------------- -------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------ -----------------------
  Larsen PA et al, 1978             76/Female       Aphakic bullous keratopathy                   48 days                    Positive (donor rim and fluid)                                                               Topical and intravenous amphotericin B, oral and topical flucytosine                                                                                   Renal toxicity; death
  Cameron JA et al, 1991            22/Male         Keratoconus                                   7 days                     Positive (donor rim)                                                                         Intravitreal amphotericin B, subconjunctival miconazole, topical natamycin,oral flucytocine                                                            Not stated
  Antonios et al, 1991              30/Male         Cornea scar                                   11 days                    Positive (donor rim)                                                                         Not stated                                                                                                                                             Not stated
  Cameron JA et al, 1998            46/Male         Cornea scar                                   3 weeks                    Positive (donor rim)                                                                         Not stated                                                                                                                                             Not stated
  Chapman FM et al, 1998            43/Male         Keratoconus                                   4 days                     Positive (transport medium)                                                                  Topical,intracameral and subconjunctival amphotericin B                                                                                                Nil
  Garcia-Valenzuela E et al, 2005   85/Female       Fuch\'s endothelial dystrophy, pseudophakia   5 months                   Positive (donor rim)                                                                         Oral fluconazole, intravitreal and intrastromal amphotericin B,                                                                                        Not stated
  Keyhani et al, 2005               82/Female       Pseudophakia corneal oedema                   1^st^to 2^nd^week          Positive (donor rim)                                                                         Not stated                                                                                                                                             Not stated
  Grueb M et al, 2006               26/Male         Keratoconus                                   10 hours                   Positive (transport medium)                                                                  Systemic fluconazole, Topical and intracameral amphotericin B                                                                                          Nil
  Al Assiri A et al, 2006           69/Male         Trachomatous scarring                         5 months                   Positive (donor rim)                                                                         Topical and intracameral amphotericin B, systemic fluconazole                                                                                          Not stated
  Caldwell MC et al, 2009           57/Male         Post LASIK keratectasia                       10 days                    Positive (donor rim)                                                                         Oral fluconazole, intravitreal and topical amphotericin B, topical and oral voriconazole                                                               Liver toxicity
  Tappeiner C et al, 2009           70/Female       Fuch\'s endothelial dystrophy                 1 day                      Positive (donor rim)                                                                         Oral fluconazole, topical and subconjunctival amphotericin B, intravenous liposomal amphotericin B and intravenous caspofungin                         Not stated
  Tappeiner C et al, 2009           53/not stated   Fuch\'s endothelial dystrophy                 1 day                      Positive (donor rim)                                                                         Oral fluconazole and voriconazole; intracameral and subconjunctival Amphotericin B, intravenous liposomal amphotericin B and intravenous caspofungin   Renal toxicity
  Current study                     63/Male         Fuch\'s endothelial dystrophy                 2 weeks                    Negative (donor rim and transport medium) Positive (recipient AC and vitreous tap culture)   Topical, intravenous, intravitreal and intracameral amphotericin B                                                                                     Nil

Cultures of the donor rim and transport medium were negative in our patient. However, the organism was isolated successfully from the aqueous and vitreous cultures. It seems most likely that an unrecognized *Candida glabrata*infection was present in the affected eye of the recipient. It is less likely that the contamination occurred during keratoplasty as it was performed under strictly sterile condition. We believe that the patient\'s immunocompromised status facilitated the infection process.

*Candida glabrata*is resistant to fluconazole and the other azoles group of antifungal but sensitive to Amphotericin B \[[@B8]\]. Several mechanisms of azole resistance have been identified, that include increased P-450-dependent ergosterol and an energy-dependent efflux pump of fluconazole, possibly via a multidrug resistance-type transporter \[[@B13],[@B14]\]. Secondary in vitro resistance is the most common form of resistance in *candida glabrata*\[[@B15]\]. The reason for this rapid development of secondary antifungal resistance is unknown, but the haploid state of *candida glabrata*is thought to be a contributing factor \[[@B8]\].

In contrast, in vitro resistance of *candida glabrata*and *candida albicans*to ketoconazole and itraconazole accounts for only 15% but yet still significant \[[@B8]\]. Flucytosine resistance has been described extensively in *candida albicans*but not in *candida glabrata*. It has not been widely used in *candida glabrata*infections but may be useful in the future.

Fortunately, clinically significant amphotericin B resistance is still very uncommon among most *Candida*species and amphotericin B resistance has not been described in *candida glabrata*. In general, intracameral, intravitreal, intrastromal, subconjunctival, topical and systemic Amphotericin B have been used in the treatment of the *Candida glabrata*endophthalmitis \[[@B1],[@B4]-[@B7],[@B9],[@B10],[@B12]\].

Two patients developed renal toxicity after the treatment with intravenous Amphotericin, one of them subsequently died \[[@B10],[@B12]\]. Liver toxicity had been reported in a patient who was treated concurrently with oral fluconazole \[[@B4]\]. Beside the above mentioned side effects, there were no documented serious complications in *Candida glabrata*endophthalmitis patients treated with various methods of Amphotericin B delivery (Table [1](#T1){ref-type="table"}).

Fortunately, our patient did not develop any side effect during the course of Amphotericin B treatment. We had monitored him closely soon after commencing the treatment. We did not encounter retinal toxicity being reported as a side effect in our literature review though it has been mentioned in rabbit eyes \[[@B16],[@B17]\].

Beside drugs resistance, relapse of *Candida glabrata*endophthalmitis is another challenging episode among the managing ophthalmologists. It had been reported months to years after primary eradication of the infection \[[@B4],[@B6],[@B18]\]. Thus, it is very essential to monitor closely these patients as the recurrence is common.

In conclusion, *Candida glabrata*endophthalmitis is uncommon but a potentially devastating complication following penetrating keratoplasty. A complete work-up is essential to identify the source of infection and prompt treatment is indicated. This case highlights that ophthalmologists should have a high index of suspicious especially when managing patients with immunocompromised status even with negative donor and transport media cultures.
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